---
title: "Stroke and Ischemic Heart Disease Trends in Western Sub‑Saharan Africa vs Global Progress, 1990–20"
id: "medrxiv-0-divergent-trends-in-stroke-and-ischemic-heart-disease-mortality-and-disability"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-divergent-trends-in-stroke-and-ischemic-heart-disease-mortality-and-disability"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1?rss=1"
published_at: "2026-08-23T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Stroke and Ischemic Heart Disease Trends in Western Sub‑Saharan Africa vs Global Progress, 1990–20
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-divergent-trends-in-stroke-and-ischemic-heart-disease-mortality-and-disability
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1?rss=1)
- **Published At:** 2026-08-23T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This ecological trend analysis used **Global Burden of Disease (GBD) 2023** data to compare age‑standardized mortality and disability (DALYs) for **stroke** and **ischemic heart disease (IHD)** in Western Sub‑Saharan Africa (WSSA) and globally from 1990–2023. - Globally, age‑standardized mortality fell substantially: stroke by 51.7% and IHD by 38.2% between 1990 and 2023. - In WSSA, trends diverged: stroke mortality declined by only 21.8%, while IHD mortality increased by 3.3% over the same period. - Segmented regression detected a breakpoint in WSSA IHD mortality around 2007, with a shift from a declining trend to an increasing trend after that year. - **High systolic blood pressure** was the leading attributable risk factor for both stroke and IHD in the analysis. - Other risk factors with the largest relative increases in attribution were obesity, ambient air pollution, and elevated fasting glucose. - The Socio‑demographic Index (SDI) in WSSA rose by 69.5% from 1990 to 2023; SDI correlated strongly with stroke mortality (r = 0.87) but not with IHD mortality (r = 0.21). - Authors conclude WSSA is not keeping pace with global cardiovascular mortality reductions and highlight an urgent need for targeted investment in hypertension control, cardiometabolic risk reduction, and cardiovascular care capacity. - The study used publicly available, de‑identified GBD 2023 data; no new primary human subjects research or IRB approval was required. The report is a medRxiv preprint and has not been peer reviewed.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=vDrZMVglXwcFe8SEDw6jPQtDiDq2pl7HXV2vWlSm.s4-1787501338.8340285-1.2.1.1-Hd1bSXFTguThEmua7QEZ4F18uugpJgpmwx7zVgncTZx8yiqaPi62kvgpj0uGqo5V) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Divergent Trends in Stroke and Ischemic Heart Disease Mortality and Disability in Western Sub-Saharan Africa Compared with Global Progress, 1990-2023 [ View ORCID Profile](http://orcid.org/0009-0002-8748-6260)Prince Ankrah-Twumasi, Jeffrey Jerry Vladimir Ofori, [ View ORCID Profile](http://orcid.org/0000-0002-7206-6207)Prince Pekyi-Boateng, Yaw Twerefour, Dorcas Sackey doi: https://doi.org/10.64898/2026.08.19.26360860 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Prince Ankrah-Twumasi 1 University of Aberdeen; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Prince%2BAnkrah-Twumasi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ankrah-Twumasi%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APrince%2BAnkrah-Twumasi%2B) * [ORCID record for Prince Ankrah-Twumasi](http://orcid.org/0009-0002-8748-6260 "Open in new tab") * For correspondence: p.ankrah-twumasi.25@abdn.ac.uk Jeffrey Jerry Vladimir Ofori 2 Tema General Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jeffrey%2BJerry%2BVladimir%2BOfori%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Ofori%20JJ&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJeffrey%2BJerry%2BVladimir%2BOfori%2B) Prince Pekyi-Boateng 3 University of Utah Health; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Prince%2BPekyi-Boateng%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Pekyi-Boateng%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APrince%2BPekyi-Boateng%2B) * [ORCID record for Prince Pekyi-Boateng](http://orcid.org/0000-0002-7206-6207 "Open in new tab") Yaw Twerefour 4 Ghana Health Service; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yaw%2BTwerefour%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Twerefour%20Y&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYaw%2BTwerefour%2B) Dorcas Sackey 5 Harvard Medical School * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dorcas%2BSackey%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Sackey%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADorcas%2BSackey%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1283978/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1283978/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1283978/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1283978/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1283978/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background Cardiovascular disease remains the leading cause of death worldwide, yet progress in reducing its burden has not been shared equally across regions. Sub-Saharan Africa has previously been identified as the only world region where age-standardized cardiovascular mortality failed to decline, but long-term, disease-specific trends in Western Sub-Saharan Africa (WSSA) remain poorly characterized. Methods We conducted an ecological trend analysis using Global Burden of Disease (GBD) 2023 data to evaluate age-standardized mortality and disability-adjusted life years (DALYs) for stroke and ischemic heart disease (IHD) in WSSA and globally from 1990 to 2023. Linear and segmented regression assessed long-term trends and breakpoints, risk factor attribution examined six major cardiovascular risk factors, and Pearson correlation evaluated associations between the Socio-demographic Index (SDI) and mortality. Results Global stroke and IHD mortality declined by 51.7% and 38.2%, respectively, between 1990 and 2023. In WSSA, stroke mortality declined by only 21.8%, while IHD mortality increased by 3.3%. Segmented regression identified a breakpoint in IHD mortality around 2007, after which the trend reversed from declining to increasing. High systolic blood pressure was the leading attributable risk factor for both diseases, while obesity, ambient air pollution, and elevated fasting glucose showed the largest relative increases. SDI rose 69.5% in WSSA but correlated strongly only with stroke mortality (r = 0.87), not IHD (r = 0.21). Conclusions WSSA is falling behind global cardiovascular progress, with IHD mortality reversing course despite substantial socioeconomic development. Targeted investment in hypertension control, cardiometabolic risk reduction, and cardiovascular care capacity is urgently needed to prevent this divergence from deepening. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics approval was not required for this study because it involved secondary analysis of publicly available, de-identified data from the Global Burden of Disease 2023 Study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data used in this study were obtained from the Global Burden of Disease (GBD) 2023 Study and are publicly available through the Institute for Health Metrics and Evaluation (IHME) data repository. The datasets analyzed during the current study are available from the corresponding sources and can be accessed without restriction. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY 4.0 International license](http://creativecommons.org/licenses/by/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.08.18.26360762v1 "WHY A "NORMAL BLOOD VOLUME" IS NOT ALWAYS NORMAL – AN OVERLOOKED ISSUE IN HEART FAILURE MANAGEMENT") Posted August 23, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/08/23/2026.08.19.26360860.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.08.19.26360860v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/08/23/2026.08.19.26360860.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Divergent Trends in Stroke and Ischemic Heart Disease Mortality and Disability in Western Sub-Saharan Africa Compared with Global Progress, 1990-2023 Prince Ankrah-Twumasi, Jeffrey Jerry Vladimir Ofori, Prince Pekyi-Boateng, Yaw Twerefour, Dorcas Sackey medRxiv 2026.08.19.26360860; doi: https://doi.org/10.64898/2026.08.19.26360860 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.19.26360860v1%26text%3DDivergent%2520Trends%2520in%2520Stroke%2520and%2520Ischemic%2520Heart%2520Disease%2520Mortality%2520and%2520Disability%2520in%2520Western%2520Sub-Saharan%2520Africa%2520Compared%2520with%2520Global%2520Progress%252C%25201990-2023 "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.19.26360860v1%26t%3DDivergent%2520Trends%2520in%2520Stroke%2520and%2520Ischemic%2520Heart%2520Disease%2520Mortality%2520and%2520Disability%2520in%2520Western%2520Sub-Saharan%2520Africa%2520Compared%2520with%2520Global%2520Progress%252C%25201990-2023 "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.19.26360860v1%26title%3DDivergent%2520Trends%2520in%2520Stroke%2520and%2520Ischemic%2520Heart%2520Disease%2520Mortality%2520and%2520Disability%2520in%2520Western%2520Sub-Saharan%2520Africa%2520Compared%2520with%2520Global%2520Progress%252C%25201990-2023%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.08.19.26360860v1%26title%3DDivergent%2520Trends%2520in%2520Stroke%2520and%2520Ischemic%2520Heart%2520Disease%2520Mortality%2520and%2520Disability%2520in%2520Western%2520Sub-Saharan%2520Africa%2520Compared%2520with%2520Global%2520Progress%252C%25201990-2023 "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.08.19.26360860) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.08.19.26360860v1&count=horizontal&via=&text=Divergent%20Trends%20in%20Stroke%20and%20Ischemic%20Heart%20Disease%20Mortality%20and%20Disability%20in%20Western%20Sub-Saharan%20Africa%20Compared%20with%20Global%20Progress%2C%201990-2023&counturl=www.medrxiv.org/content/10.64898/2026.08.19.26360860v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (609) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (891) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (324) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4737) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (473) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (405) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (638) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1608) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (15771) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (32) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1193) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (6946) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (724) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1049) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (4941) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1419) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1729) * [Hematology](https://www.medrxiv.org/collection/hematology) (575) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1323) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16220) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1155) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (657) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (150) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (715) * [Neurology](https://www.medrxiv.org/collection/neurology) (7134) * [Nursing](https://www.medrxiv.org/collection/nursing) (359) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1070) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1218) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (992) * [Oncology](https://www.medrxiv.org/collection/oncology) (3557) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1030) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (387) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (442) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (463) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (138) * [Pathology](https://www.medrxiv.org/collection/pathology) (702) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1765) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (730) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (756) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (5800) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9646) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2364) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1421) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1235) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (631) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (762) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (571) * [Surgery](https://www.medrxiv.org/collection/surgery) (756) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (106) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (300) * [Urology](https://www.medrxiv.org/collection/urology) (285) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There i
## Related Clinical Research

- [Stopping Statins at Age 75 in Low‑Risk Adults: French Trial Found No Increase in Deaths](https://medichelpline.com/clinical-feed/stat-news-0-stopping-statins-in-people-over-75-at-low-risk-for-heart-disease-didn-t.md)
- [Forecasting Cardiovascular Disease and Stroke Burden in Women Through 2050](https://medichelpline.com/clinical-feed/circulation-4-forecasting-the-burden-of-cardiovascular-disease-and-stroke-in-women-in-the-united-states-through-2050-a-scientific-statement-from-the-american-heart-association.md)
- [Lifestyle Changes May Help Prevent Multimorbidity In Prediabetes](https://medichelpline.com/clinical-feed/medical-news-today-23-diet-weight-loss-and-150-minutes-of-exercise-may-protect-against-chronic.md)
- [Moving Forward: The Future of GLP-1 Therapies](https://medichelpline.com/clinical-feed/endocrine-news-18-moving-forward-the-future-of-glp-1-therapies.md)
- [Intensive blood pressure control linked to 15% lower 7-year dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-intensive-blood-pressure-control-cuts-7-year-dementia-risk-by-15-study-finds.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.